Novozymes B A/S

NZYM-B 
(NasdaqOMXC) 
 
dkk 350.10 <%= Resources.Global.txtUp %>
Updated 15:59:40
Change % 0.20% Stock price increasing
Change 0.70 Stock price increasing
Volume 271,492
High DKK 351.20
Low DKK 346.10
Open DKK 349.40
ISIN DK0060336014
Prev close DKK 349.40
# of shares 251.26M
Market cap 87,965M DKK
Intraday

Market closed
Novozymes B A/S
Market is closed, opens at 08:00
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  350.10 2.0% Stock price increasing 7.0% Stock price increasing 14.9% Stock price increasing 19.7% Stock price increasing 43.8% Stock price increasing
Key Figures (m DKK)
Turnover
EBIT
Net Profit
Equity
Balance
2015
14,002
3,884
2,825
11,593
17,791
2014
12,459
3,384
2,526
11,280
18,426
2013
11,746
2,901
2,200
11,066
16,506
2012
11,234
2,745
2,015
9,568
15,113
2011
10,510
2,340
1,828
8,824
13,842
2010
9,724
2,117
1,614
7,836
12,593
2009
8,448
1,688
1,194
5,841
0
2008
8,146
1,504
1,062
4,465
0
2007
7,438
1,481
1,042
3,657
0
Powered by TradingView

Related

Latest 1 week 1 month 3 months 6 months 1 year
YTD
 
Competitors Open
 
Archer-Daniels-Midland Company 39.57 -0.6% Stock price decreasing -9.0% Stock price decreasing -4.8% Stock price decreasing -4.7% Stock price decreasing -9.3% Stock price decreasing -13.3% Stock price decreasing
 
Internationa Flavors & Fragran.. 151.22 0.4% Stock price increasing 0.6% Stock price increasing 12.1% Stock price increasing 12.2% Stock price increasing 26.0% Stock price increasing 28.3% Stock price increasing
 
Procter & Gamble Company (The) 88.93 0.1% Stock price increasing 0.8% Stock price increasing -4.2% Stock price decreasing 3.1% Stock price increasing 7.6% Stock price increasing 5.8% Stock price increasing
 
KAO Corp 52.24 0.5% Stock price increasing -2.2% Stock price decreasing 1.4% Stock price increasing 73.4% Stock price increasing 73.4% Stock price increasing 73.4% Stock price increasing
 
Lonza Group AG NA SF 1 224.24 1.7% Stock price increasing 1.6% Stock price increasing 10.8% Stock price increasing 172.8% Stock price increasing 172.8% Stock price increasing 172.8% Stock price increasing
 
Reckitt Benckiser Group PLC OR.. 6,401.00 -0.2% Stock price decreasing -3.2% Stock price decreasing -11.8% Stock price decreasing -16.0% Stock price decreasing -6.8% Stock price decreasing -7.0% Stock price decreasing
 
Basf SE NA O.N. 93.57 0.6% Stock price increasing 3.4% Stock price increasing 16.3% Stock price increasing 9.1% Stock price increasing 16.7% Stock price increasing 6.0% Stock price increasing
 
Givaudan SA NA SF 10 1,897.00 -2.1% Stock price decreasing 1.9% Stock price increasing 12.1% Stock price increasing 3.8% Stock price increasing 12.8% Stock price increasing 8.6% Stock price increasing
 
Monsanto Company 118.26 0.2% Stock price increasing -3.2% Stock price decreasing 1.2% Stock price increasing 1.9% Stock price increasing 16.7% Stock price increasing 12.4% Stock price increasing
 
Syngenta AG NA SF 0,1 397.05 1.2% Stock price increasing 3.1% Stock price increasing 2.6% Stock price increasing -4.2% Stock price decreasing 9.7% Stock price increasing 5.1% Stock price increasing
 
DSM KON 79.52 4.9% Stock price increasing 9.4% Stock price increasing 25.5% Stock price increasing 20.2% Stock price increasing 41.2% Stock price increasing 39.6% Stock price increasing
 
Solvay 120.45 -0.2% Stock price decreasing -3.6% Stock price decreasing -1.0% Stock price decreasing 2.3% Stock price increasing 19.0% Stock price increasing 8.2% Stock price increasing
 
Unilever DR 48.71 0.6% Stock price increasing 1.9% Stock price increasing -2.1% Stock price decreasing -1.1% Stock price decreasing 32.9% Stock price increasing 24.5% Stock price increasing
 
Givaudan N 2,283.00 1.2% Stock price increasing 5.5% Stock price increasing 18.0% Stock price increasing 14.5% Stock price increasing 26.9% Stock price increasing 22.3% Stock price increasing
 
Lonza N 264.90 3.0% Stock price increasing 3.3% Stock price increasing 15.1% Stock price increasing 33.9% Stock price increasing 45.8% Stock price increasing 50.3% Stock price increasing
 
Syngenta N 457.50 -0.1% Stock price decreasing 1.2% Stock price increasing 3.7% Stock price increasing 1.0% Stock price increasing 18.0% Stock price increasing 13.7% Stock price increasing
 
Cropenergies AG 9.16 1.9% Stock price increasing -2.6% Stock price decreasing 0.0% Stock price decreasing 0.7% Stock price increasing 92.7% Stock price increasing 79.6% Stock price increasing
 
Codexis Inc 5.80 -1.7% Stock price decreasing -20.5% Stock price decreasing 10.5% Stock price increasing 33.3% Stock price increasing 16.0% Stock price increasing 26.1% Stock price increasing
 
Chr Hansen Holding A/S 583.00 3.2% Stock price increasing 7.1% Stock price increasing 11.8% Stock price increasing 26.8% Stock price increasing 49.1% Stock price increasing 49.1% Stock price increasing
Indices Open
 
OMX Copenhagen 20 CAP 1,121.54 0.8% Stock price increasing -5.2% Stock price decreasing -2.7% Stock price decreasing -1.8% Stock price decreasing 17.0% Stock price increasing 10.0% Stock price increasing

Company profile

Novozymes(NZYM) is split in two business divisions: Enzymes Business and BioBusiness. NZYM is the world’s leading player within industrial enzymes with 47% of the global market, which is estimated to be around DKK 19bn in total. Enzymes comprises the largest part of the revenue (2010: 94%, 2009: 92%) and is split into four sub segments of which one is technical enzymes, where sales of enzymes to the bioethanol industry take place (2010 Rev: 19%, mainly from North America). NZYM invests a large part of their R&D costs in development of bioethanol; massive production will however not take place before 2012/13. The largest competitors in this segment are Danisco and DSM. NZYM puts its focus on cost reductions, innovation and efficiency, seeing growth opportunities in the developing world. NZYM has no plans of major acquisitions after having acquired EMD/Merck Crop BioScience in 2011. With over 6,500 granted or pending patents, NZYM aims to achieve long-term organic sales growth of more than 10% p.a (hist.avg.: 8-9%) and increased dividend pay-out ratio to 35% of net profit (curr.: 30%).

Peers

Indices Last Change  
OMX C20 Cap 1,121.54 -0.3% Stock price decreasing
100,63,86,64,46,45,15,27,44,57
Instruments Last Change  
Archer-Danie.. 39.57 0.9% Stock price increasing
Internationa.. 151.22 0.9% Stock price increasing
Procter & Ga.. 88.93 0.7% Stock price increasing
KAO Corp 52.24 1.2% Stock price increasing
0,0,0,0,0,100,100,100,100,100
Lonza Group .. 224.24 0.8% Stock price increasing
0,0,0,8,8,8,100,100,100,100
Reckitt Benc.. 6,401.00 0.3% Stock price increasing
Basf SE NA O.. 93.57 1.1% Stock price increasing
Givaudan SA .. 1,897.00 0.0% Stock price unchanged
Monsanto Com.. 118.26 0.1% Stock price increasing
Syngenta AG .. 397.05 0.0% Stock price unchanged
DSM KON 79.52 1.4% Stock price increasing
Solvay 120.45 -1.1% Stock price decreasing
Unilever DR 48.71 0.9% Stock price increasing
Givaudan N 2,283.00 -0.3% Stock price decreasing
5,78,63,31,47,68,57,73,52,26
Lonza N 264.90 0.9% Stock price increasing
14,64,85,66,56,81,72,91,91,95
Syngenta N 457.50 -0.3% Stock price decreasing
100,42,42,0,14,85,14,0,57,0
Cropenergies.. 9.16 0.0% Stock price unchanged
Codexis Inc 5.80 0.0% Stock price unchanged
16,16,0,16,66,83,50,66,83,100
Chr Hansen H.. 583.00 1.0% Stock price increasing
14,52,66,71,57,57,57,71,90,95

Targets for: Novozymes B A/S

Ritzau Finans
 
Analyst
Target
Date
Novozymes/UBS: Indleder dækning med
UBS
240
19/06/17
Novozymes/Bernstein: Hæver kursmålet til 310 kr.
Bernstein
310 op
07/04/17

Copyright Euroinvestor A/S 2017   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 November 2017 17:43:56
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20171108.1 - EUROWEB5 - 2017-11-21 18:43:56 - 2017-11-21 17:43:56 - 1000 - Website: OKAY